Sign in to continue:

Saturday, April 11th, 2026

Jet.AI Inc. Announces 1-for-200 Reverse Stock Split to Maintain Nasdaq Listing Compliance




Jet.AI Inc. Announces 1-for-200 Reverse Stock Split

Jet.AI Inc. Announces 1-for-200 Reverse Stock Split to Maintain Nasdaq Listing

Key Developments

  • Reverse Stock Split: Jet.AI Inc. (Nasdaq: JTAI) has announced a 1-for-200 reverse stock split of its outstanding shares of common stock, effective before the market opens on Wednesday, April 8, 2026.
  • Trading and CUSIP Update: The company’s shares will continue to trade under the symbol “JTAI” on the Nasdaq Capital Market, with a new CUSIP number of 47714H407 following the split.
  • Shares Outstanding: As of April 6, 2026, Jet.AI has 129,362,471 shares of common stock issued and outstanding. After the split, this number will be reduced to approximately 646,812 shares.

Details and Rationale

The reverse stock split will see every 200 existing shares automatically converted into one new share, with no change to the par value per share or the total number of authorized shares. The move is primarily designed to enable Jet.AI to maintain compliance with Nasdaq’s minimum bid price requirement for continued listing. Additionally, the split will make more shares of common stock available for future issuance, an important consideration for potential fundraising, acquisitions, or equity incentives.

The company emphasized that the reverse split will affect all shareholders uniformly and will not alter any shareholder’s proportional ownership in Jet.AI, except in cases where fractional shares would result. No fractional shares will be issued; instead, shareholders entitled to a fractional share will receive a cash payment in lieu of such fraction.

Proportional adjustments will be made to the number of shares issuable upon exercise or conversion of the company’s equity awards, convertible preferred stock, and warrants, as well as the applicable exercise or conversion prices. Stockholders with shares in brokerage accounts will see their holdings automatically adjusted, while others may contact the company’s transfer agent, Continental Stock Transfer & Trust Company, for assistance.

Potential Impact for Investors and Shareholders

  • Nasdaq Compliance: The reverse split is a critical step for Jet.AI to avoid delisting from the Nasdaq Capital Market due to non-compliance with the minimum bid price rule. This could be price-sensitive, as maintaining listing status typically supports shareholder value and liquidity.
  • Share Price and Liquidity: The immediate effect of the reverse split will be a higher trading price per share due to the reduced share count. However, actual price movement will depend on market perception and investor sentiment post-split.
  • Fractional Shares: No investor will be left holding a fractional share; instead, they will receive a cash payment. This is a standard practice but should be noted by shareholders with odd-lot positions.
  • Future Issuance Potential: By freeing up shares for potential future issuance, the company is positioning itself for possible capital raises, grants, or acquisitions. This can be positive for the company’s flexibility, but investors should watch for dilution risk in the future.

Company Overview

Jet.AI Inc. is a technology-driven company focused on deploying artificial intelligence tools and infrastructure to enhance decision-making, efficiency, and performance across complex systems. The company is listed on the Nasdaq Capital Market under the ticker symbol “JTAI.”

Forward-Looking Statements

This announcement contains forward-looking statements, including but not limited to those related to Jet.AI’s strategy, Nasdaq compliance, future share issuance, and market conditions. These statements are subject to risks and uncertainties, and actual results may differ materially from those anticipated. Investors should review the company’s most recent filings with the SEC for a discussion of these risks.

Investor Contact

For further information, shareholders may contact Jet.AI’s Investor Relations via Gateway Group, Inc. at 949-574-3860 or [email protected].


Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Investors are advised to conduct their own research and consult with their financial advisors before making investment decisions. The author is not responsible for any actions taken based on the information contained herein.




View Jet.AI Inc. Historical chart here



aTyr Pharma, Inc. 2025 Annual Report: Clinical Pipeline, tRNA Synthetase Platform, Risks, and Financial Overview

aTyr Pharma, Inc. 2025 Annual Report: Key Highlights for Inv...

TScan Therapeutics, Inc. 2025 Annual Report: Business Overview, Strategy, Risks, and Pipeline Highlights

TScan Therapeutics, Inc. 2025 Annual Report — Key Investor I...

   Ad